PAPER Diniz BS, Machado-Vieira R, Forlenza OV

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.

Neuropsychiatr Dis Treat. 2013;9:493-500. PubMed: 23596350

PAPER Lane RF, Steele JW, Cai D, Ehrlich ME, Attie AD, Gandy S

Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-β peptide.

J Neurosci. 2013 Apr 17;33(16):7099-107. PubMed: 23595767

PAPER Harris JM, Gall C, Thompson JC, Richardson AM, Neary D, Du Plessis D, Pal P, Mann DM, Snowden JS, Jones M

Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia.

Neurology. 2013 May 14;80(20):1881-7. PubMed: 23596080

PAPER Jellinger KA

Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Front Aging Neurosci. 2013;5:17. PubMed: 23596414

PAPER Geerts H, Roberts P, Spiros A, Carr R

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease.

Front Pharmacol. 2013;4:47. PubMed: 23596419

Rebecca M. Pruss on Stem Cell Screen Points to ALS Disease Target

COMMENT This is an exciting paper showing the ability to use a specific class of stem cell-derived neurons—motor neurons—to screen for potential neuroprotective small molecules. While the mouse ESC-derived neural cultures appear suitable for systematic screening,

Rebecca M. Pruss

TROPHOS
Marseille, France

PAPER Rubin LL

Stem cells and drug discovery: the beginning of a new era?

Cell. 2008 Feb 22;132(4):549-52. PubMed: 18295572

PAPER Klein C, Krainc D

Glucocerebrosidase Mutations: Tipping Point Toward Parkinson Disease and Dementia?

JAMA Neurol. 2013 Apr 15;:1-3. PubMed: 23588619

PAPER Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E

A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies.

JAMA Neurol. 2013 Apr 15;:1-9. PubMed: 23588557

PAPER Farrer MJ, Williams LN, Algom AA, Kachergus J, Hulihan MM, Ross OA, Rajput A, Papapetropoulos S, Mash DC, Dickson DW

Glucosidase-beta variations and Lewy body disorders.

Parkinsonism Relat Disord. 2009 Jul;15(6):414-6. PubMed: 18829375

Branimir Nevajda

Basildon and Thurrock University Hospitals NHS Foundation Trust
London, United Kingdom

PAPER O'Keefe DT, Anthony C

The microbial metabolism of Cl compounds. The stoicheiometry of respiration-driven proton translocation in Pseudomonas AM1 and in a mutant lacking cytochrome c.

Biochem J. 1978 Mar 15;170(3):561-7. PubMed: 25651

PAPER Owens JW, Stahl P

Purification and characterization of rat liver microsomal beta-glucuronidase.

Biochim Biophys Acta. 1976 Jul 8;438(2):474-86. PubMed: 8108

PAPER Jenkins FA, Parrington FR

The postcranial skeletons of the Triassic mammals Eozostrodon, Megazostrodon and Erythrotherium.

Philos Trans R Soc Lond B Biol Sci. 1976 Feb 26;273(926):387-431. PubMed: 3813